Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-02

Clinical Trial Update: Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating effectiveness and safety of artesunate-amodiaquine and artemether-lumefantrine for treating malaria in Yaounde, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Artesunate-amodiaquine (artesunate-amodiaquine)

Snippet

Sponsor: University of Yaounde 1 | Conditions: Malaria,Falciparum | Phase 4 | Status: COMPLETED